2023 Publications

Bolaamphiphile Analogues of 12-bis-THA Cl(2) are potent antimicrobial therapeutics with distinct mechanisms of action against bacterial, mycobacterial, and fungal pathogens. (2023) Di Blasio, S., M. Clarke, C. K. Hind, M. Asai, L. Laurence, A. Benvenuti, M. Hassan, D. Semenya, D. K. Man, V. Horrocks, G. Manzo, S. Van Der Lith, C. Lam, E. Gentile, C. Annette, J. Bosse, Y. Li, B. Panaretou, P. R. Langford, B. D. Robertson, J. K. W. Lam, J. M. Sutton, M. McArthur and A. J. Mason. mSphere 8(1): e0050822 https://doi.org/10.1128/msphere.00508-22

Clinical utility of C-reactive protein-based triage for presumptive pulmonary tuberculosis in South African adults. (2023) Calderwood, C. J., B. W. Reeve, T. Mann, Z. Palmer, G. Nyawo, H. Mishra, G. Ndlangalavu, I. Abubakar, M. Noursadeghi, G. Theron and R. K. Gupta. J Infect 86(1): 24-32 https://doi.org/10.1016/j.jinf.2022.10.041

Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-alpha inhibitor initiation in children in Spain. (2023) Calzada-Hernandez, J., J. Anton, J. Martin de Carpi, B. Lopez-Montesinos, I. Calvo, E. Donat, E. Nunez, J. Blasco Alonso, M. J. Mellado, F. Baquero-Artigao, R. Leis, A. M. Vegas-Alvarez, M. Medrano San Ildefonso, M. D. C. Pinedo-Gago, F. J. Eizaguirre, A. Tagarro, M. Camacho-Lovillo, B. Perez-Gorricho, C. Gavilan-Martin, S. Guillen, B. Sevilla-Perez, L. Pena-Quintana, P. Mesa-Del-Castillo, C. Fortuny, M. Tebruegge and A. Noguera-Julian. Eur J Pediatr 182(1): 307-317 https://doi.org/10.1007/s00431-022-04640-3

Economic evaluation of shortened, bedaquiline-containing treatment regimens for rifampicin-resistant tuberculosis (STREAM stage 2): a within-trial analysis of a randomised controlled trial. (2023) Rosu, L., J. J. Madan, E. M. Tomeny, M. Muniyandi, J. Nidoi, M. Girma, V. Vilc, P. Bindroo, R. Dhandhukiya, A. K. Bayissa, D. Meressa, G. Narendran, R. Solanki, A. K. Bhatnagar, E. Tudor, B. Kirenga, S. K. Meredith, A. J. Nunn, G. Bronson, I. D. Rusen, S. B. Squire, E. Worrall and S. S. H. E. E. Collaborators. Lancet Glob Health 11(2): e265-e277 https://doi.org/10.1016/S2214-109X (22)00498-3

Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa. (2023) du Bruyn, E., C. Stek, R. Daroowala, Q. Said-Hartley, M. Hsiao, G. Schafer, R. T. Goliath, F. Abrahams, A. Jackson, S. Wasserman, B. W. Allwood, A. G. Davis, R. P. Lai, A. K. Coussens, K. A. Wilkinson, J. de Vries, N. Tiffin, M. Cerrone, N. A. B. Ntusi, H. consortium, C. Riou and R. J. Wilkinson. Nat Commun 14(1): 188 https://doi.org/10.1038/s41467-022-35689-1

Forgiveness Is the attribute of the strong: Nonadherence and regimen shortening in drug-sensitive tuberculosis. (2023) Stagg, H. R., J. A. Thompson, M. C. I. Lipman, D. J. Sloan, M. Flook and K. L. Fielding. Am J Respir Crit Care Med 207(2): 193-205 https://doi.org/10.1164/rccm.202201-0144OC

Genome-Wide Association with Uncertainty in the Genetic Similarity Matrix. (2023) Wang, S., S. Ge, B. Sobkowiak, L. Wang, L. Grandjean, C. Colijn and L. T. Elliott. J Comput Biol 30(2): 189-203 https://doi.org/10.1089/cmb.2022.0067

Identification and control for the effects of bioinformatic globin depletion on human RNA-seq differential expression analysis. (2023) Sheerin, D., F. Lakay, H. Esmail, C. Kinnear, B. Sansom, B. Glanzmann, R. J. Wilkinson, M. E. Ritchie and A. K. Coussens. Sci Rep 13(1): 1859 https://doi.org/10.1038/s41598-023-28218-7

Indirect effects of cytomegalovirus infection: Implications for vaccine development. (2023) Moseley, P., P. Klenerman and S. Kadambari. Rev Med Virol 33(1): e2405 https://doi.org/10.1002/rmv.2405

Novel FujiLAM assay to detect tuberculosis in HIV-positive ambulatory patients in four African countries: a diagnostic accuracy study. (2023) Huerga, H., M. Bastard, A. V. Lubega, M. Akinyi, N. T. Antabak, L. Ohler, W. Muyindike, I. M. Taremwa, R. Stewart, C. Bossard, N. Nkosi, Z. Ndlovu, C. Hewison, T. Stavia, G. Okomo, J. O. Ogoro, J. Ngozo, M. Mbatha, C. Aleny, S. Wanjala, M. Musoke, D. Atwine, A. Ascorra, E. Ardizzoni, M. Casenghi, G. Ferlazzo, L. Nakiyingi, A. Gupta-Wright and M. Bonnet. Lancet Glob Health 11(1): e126-e135 https://doi.org/10.1016/S2214-109X (22)00463-6

Performance of QuantiFERON-TB Gold Plus assays in paediatric tuberculosis: a multicentre PTBNET study. (2023) Buonsenso, D., A. Noguera-Julian, R. Moroni, A. Hernandez-Bartolome, N. Fritschi, L. Lancella, L. Cursi, A. Soler-Garcia, R. Kruger, C. Feiterna-Sperling, M. Sali, A. Lo Vecchio, S. Scarano, A. Hernanz Lobo, M. Espiau, A. Soriano-Arandes, B. S. Cetin, F. Brinkmann, I. Ozere, F. Baquero-Artigao, M. Tsolia, T. Milheiro Silva, M. Bustillo-Alonso, A. Martin Nalda, M. Mancini, A. Starshinova, N. Ritz, S. Velizarova, L. Ferreras-Antolin, F. Gotzinger, O. Bilogortseva, V. Chechenyeva, M. Tebruegge, B. Santiago-Garcia and Q. F. T. P. s. g. ptbnet. Thorax 78(3): 288-296 https://doi.org/10.1136/thorax-2022-218929

Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysis. (2023) Hamada, Y., R. K. Gupta, M. Quartagno, A. Izzard, C. Acuna-Villaorduna, N. Altet, R. Diel, J. Dominguez, S. Floyd, A. Gupta, H. Huerga, E. C. Jones-Lopez, A. Kinikar, C. Lange, F. van Leth, Q. Liu, W. Lu, P. Lu, I. L. Rueda, L. Martinez, S. K. Mbandi, L. Munoz, E. S. Padilla, M. Paradkar, T. Scriba, M. Sester, K. Shanaube, S. K. Sharma, R. Sloot, G. Sotgiu, K. Thiruvengadam, R. Vashishtha, I. Abubakar and M. X. Rangaka. EClinicalMedicine 56: 101815 https://doi.org/10.1016/j.eclinm.2022.101815

Prevalence and predictive factors of tuberculosis treatment interruption in the Asia region: a systematic review and meta-analysis. (2023) Oh, A. L., M. Makmor-Bakry, F. Islahudin and I. C. Wong. BMJ Glob Health 8(1) https://doi.org/10.1136/bmjgh-2022-010592

Pyrimidine derivatives with antitubercular activity. (2023) Finger, V., M. Kufa, O. Soukup, D. Castagnolo, J. Roh and J. Korabecny. Eur J Med Chem 246: 114946 https://doi.org/10.1016/j.ejmech.2022.114946

Regimens for Drug-Resistant Tuberculosis. Reply. (2023) Timm, J., A. M. Crook and E. Sun. N Engl J Med 388(2): 190-191 https://doi.org/10.1056/NEJMc2213970

The roles of neutrophils in non-tuberculous mycobacterial pulmonary disease. (2023) Alkarni, M., M. Lipman and D. M. Lowe. Ann Clin Microbiol Antimicrob 22(1): 14 https://doi.org/10.1186/s12941-023-00562-6

Scaling up evidence-based approaches to tuberculosis screening in prisons. (2023) Charalambous, S., K. Velen, Z. Rueda, J. Croda, M. E. Herce, S. V. Shenoi, F. L. Altice, M. Muyoyeta, L. Telisinghe, L. Grandjean, S. Keshavjee and J. R. Andrews. Lancet Public Health https://doi.org/10.1016/S2468-2667 (23)00002-6

T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection. (2023) Musvosvi, M., H. Huang, C. Wang, Q. Xia, V. Rozot, A. Krishnan, P. Acs, A. Cheruku, G. Obermoser, A. Leslie, S. M. Behar, W. A. Hanekom, N. Bilek, M. Fisher, S. H. E. Kaufmann, G. Walzl, M. Hatherill, M. M. Davis, T. J. Scriba, t. Adolescent Cohort Study and G. C. Consortium. Nat Med 29(1): 258-269 https://doi.org/10.1038/s41591-022-02110-9

Treatment Strategy for Rifampin-Susceptible Tuberculosis. (2023) Paton, N. I., C. Cousins, C. Suresh, E. Burhan, K. L. Chew, V. B. Dalay, Q. Lu, T. Kusmiati, V. M. Balanag, S. L. Lee, R. Ruslami, Y. Pokharkar, I. Djaharuddin, J. J. R. Sugiri, R. S. Veto, C. Sekaggya-Wiltshire, A. Avihingsanon, R. Sarin, P. Papineni, A. J. Nunn, A. M. Crook and T.-T. T. Team. N Engl J Med https://doi.org/10.1056/NEJMoa2212537

2023 Publications

Other Outputs